Synertec details $45.5M government contract
- Synertec disclosed the Australian Nuclear Science and Technology Organisation as the client behind its eight-year, $45.5 million engineering services agreement.
- The contract value represents 2.4 times the engineering division's external revenue for FY26.
- Synertec expects to recognise $36 million of revenue during the initial 26-month design phase.
Synertec (ASX:SOP) confirmed the Australian Nuclear Science and Technology Organisation awarded its $45.5 million engineering services contract.
The eight-year deal matches 2.4 times the external revenue generated by Synertec's engineering division in FY26.
The initial 26-month design phase begins on Sept. 21 and is projected to deliver $36 million in revenue.
Synertec stated that project contribution margins are expected to exceed 25% while maintaining positive cumulative cash flow for over 90% of the programme.
Following the announcement the Synertec share price was unchanged at $0.082.
The contract forms part of the Nuclear Medicine Manufacturing Programme to construct a replacement radiopharmaceutical production facility at Lucas Heights, New South Wales.
Synertec will serve as the lead for process design, systems engineering, facility integration, and commissioning support services.
